AIIMS Delhi to start Covaxin trials on children in few days
ANI
03 Jun 2021, 21:55 GMT+10
By Shalini BhardwajNew Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech s COVID-19 vaccine Covaxin in few days, sources said on Thursday.
The paediatric trials for Covaxin started in AIIMS Patna on Tuesday after Bharat Biotech s COVID-19 vaccine received the Drugs Controller General of India (DCGI) nod to conduct clinical trials on children on May 11. AIIMS Patna has started trials in the age of 12-18 years, we have started clinical trials of Covaxin after registration for this age only, said Dr Prabhat Kumar Singh, Director, AIIMS, Patna.
MISSOULA, Mont. - New data released from the CDC shows drug, alcohol and suicide-related deaths are all on the rise in Montana. But the number that is most alarming is